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Continuous Positive Airway
Pressure After Circumferential
Pulmonary Vein Isolation
The Recipe for Improving the Success Rate
of Ablation in Patients With Obstructive
Sleep Apnea and Atrial Fibrillation?*
Bernard Belhassen, MD
Tel-Aviv, IsraelCatheter ablation of atrial ﬁbrillation (AF) is increasingly
performed in most electrophysiologic centers worldwide,
resulting in long-term arrhythmia control/cure rates 70%
(1). The procedure includes segmental or circumferential
pulmonary vein isolation (CPVI). The vast majority of
patients undergoing AF ablation are male (72% incidence
rate in a multicenter international survey involving 35,000
patients (Michowitz et al., unpublished data). During the
last 2 decades, obstructive sleep apnea (OSA), a common
and previously believed benign disorder, has been shown to
be strongly correlated with AF (2) and substantial cardio-
vascular morbidity and mortality (3).See page 300OSA is much more prevalent in males than females. In
1 study involving middle-aged apparently healthy subjects
(4), OSA was found in 25% of men and in 9% of women.
Therefore, it represents an important medical issue in the
predominantly male patient population candidate to AF
ablation procedures. Another study demonstrated that
approximately two-thirds (62%) of patients with parox-
ysmal or persistent AF suffered from OSA as compared to
38% of control patients (5). Also, high-frequency AF was
associated with a higher prevalence and severity of OSA
(5). In a recent meta-analysis OSA was found to be
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relevant to the contents of this paper to disclose.ablation of AF using radiofrequency energy (6). Similar
results were observed in patients undergoing cryoballoon
ablation of AF (7).
Continuous positive airway pressure (CPAP) is the most
effective treatment for OSA, in which the mild pressure
from CPAP prevents the airway from collapsing or
becoming blocked. While the deleterious effects of OSA on
the results of AF ablation are well established, information
on the effects of CPAP on AF recurrence after ablation is
scarce. Patel et al. (8) were the ﬁrst to study the effects of
CPAP on the results of AF ablation in OSA patients. In
a retrospective study involving a large cohort population
(n ¼ 640), they found that the use of CPAP treatment
signiﬁcantly lowered the AF recurrence rate after ablation of
paroxysmal AF in patients with OSA (21% in the CPAP
group vs. 32% in the non-CPAP group at 32  14 months
follow-up; p ¼ 0.019).
In this issue of the Journal, Fein et al. (9) from Boston
studied a group of 62 patients with a polysomnography-
conﬁrmed diagnosis of OSA who underwent AF ablation.
The latter included PVI in all patients with left atrial
ablation lines in selected cases. The authors examined
the effect of CPAP in 2 groups of patients: “CPAP users”
(n ¼ 32) and “CPAP non-users” (n ¼ 30). They found that
OSA patients treated with CPAP exhibited a lower AF
recurrence rate than the non treated patients (28% vs. 63%
at 12-month follow-up; p ¼ 0.01). Fein et al. (9) also
reached 2 other important conclusions: 1) CPAP therapy
resulted in improved arrhythmia-free survival that was not
different than that of patients without OSA; and
2) untreated OSA patients who underwent ablation had an
increased risk of arrhythmia recurrence that was similar to
that of OSA patients treated medically without ablation.
The results of Fein et al. (9) conﬁrm in a greater extent
those observed by Patel et al. (8) and have important clinical
implications:
1. Since ablation is increasingly offered to AF patients,
those with associated OSA should not be discouraged
to undergo the procedure, just because a higher rate of
AF recurrence is expected after ablation. Instead they
must be offered this therapeutic option and encour-
aged to adhere strictly to CPAP therapy following AF
ablation.
2. Taking in account the high prevalence of OSA in
patients with refractory AF after repeated ablation
procedures (10), one should recommend the systematic
monitoring of these patients for OSA. In those
patients in whom OSA is diagnosed, CPAP therapy
rather than repeat ablation may be a better initial
choice.
3. Factors aggravating OSA and frequently present in
AF patients are well known: obesity, alcohol con-
sumption, diabetes, and smoking. The fact that
CPAP has been shown to decrease AF recurrence after
ablation in patients with OSA suggests that the
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307treatment of any of these factors might also indirectly
improve patients outcome after AF ablation.
Several mechanisms have been proposed to explain the
induction of AF by OSA (11): intermittent hypoxia and
hypercapnia, increased sympathetic tone, cardiac diastolic
dysfunction leading to left atrial stretch, inﬂammatory
response, and endothelial dysfunction. Recently, Linz et al.
(12) showed that negative tracheal pressure during obstructive
events is a strong trigger for AF compared with changes in
blood gases alone, resulting in enhanced vagal activation that
in turn causes shortening of the atrial effective refractory
period and increased susceptibility to AF. CPAP therapy is
likely to effectively reverse these mechanisms and thereby
decrease AF occurrence.
There are several limitations in Fein et al.’s study (9). The
most important is the retrospective study design that did
not allow systematic polysomnography for all patients and
could have been a subject to selection bias. For example the
62 study patients with OSA represented only 14.5% of the
initial cohort population (n ¼ 426) that comprised a high
percentage of male patients suffering from hypertension and
diabetes at high risk of OSA. Another limitation concerns
the control group of OSA patients managed medically
without ablation. This group of patients was not part of the
AF ablation database although many of them were probably
good candidates for an ablation procedure. The authors
recommended that “some caution should be made in
extrapolating too much from its comparison to the ablation
group.” I would certainly agree with this statement. Finally
the authors used a deﬁnition of “blanking period” (2 weeks)
that was much shorter than the 1 recommended in an in-
ternational consensus document (3 months) (13). Although
this deﬁnition might not have affected the comparison
between their study groups, it renders objective comparison
with the results of other studies using the standard deﬁnition
more difﬁcult.
Treatment of OSA before ablation can help reduce AF
recurrence, allowing for more efﬁcient treatment of AF (14).
It is thus important for physicians to monitor AF patients
for OSA and monitor those with OSA for AF (14). The
results of Fein et al. (9) and Patel et al. (8) suggest that
treatment of OSA after AF ablation will also achieve the
same goal. Conﬁrmation of these results in randomized
controlled trials will certainly represent a great advance in
our management of patients with AF and OSA, 2 rapidly
growing epidemic plagues in the Western world.
A recently published paper by Naruse et al. (15) conﬁrms
the beneﬁcial effects of CPAP on the results of AF ablation
in OSA patients.Reprint requests and correspondence: Dr. Bernard Belhassen,
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